RIVANNA receives FDA 510(k) clearance for Accuro XV musculoskeletal ultrasound imaging system

B CHARLOTTESVILLE, Va., May 7, 2026 /PRNewswire/ — RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA)…
posteditor
posteditor
Articles: 21727

Other News